5-hydroxytryptamine receptor 6 — Drug Target

All drugs that target 5-hydroxytryptamine receptor 6 — marketed and clinical-stage. Includes 6 drug classes acting on this target.

Drug classes

Monoamine Oxidase Inhibitor · Sulfone [EPC] · Estrogen Agonist/Antagonist · mitotane · clopenthixol · High Risk QT Prolonging Agents

Marketed (4)

• Azilect · Teva · Monoamine Oxidase Inhibitor · Metabolic
• Aczone · Almirall · Sulfone [EPC] · Immunology
  Aczone works by inhibiting bacterial growth and reducing inflammation through its sulfone properties.
• Fareston · Kyowa Kirin · Estrogen Agonist/Antagonist · Oncology
  Fareston works by binding to estrogen receptors in the body, which can help reduce the growth of breast cancer cells.
• Lysodren · Esteve · mitotane · Oncology
  Lysodren works by inhibiting the production of cortisol and aldosterone in the adrenal cortex.

Phase 2 pipeline (1)

• Sordinol · clopenthixol · Neuroscience
  Sordinol works by blocking the 5-hydroxytryptamine receptor 6, which helps to regulate mood and behavior.